Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
2.850
-0.140 (-4.68%)
At close: Apr 1, 2025, 4:00 PM
2.844
-0.006 (-0.22%)
After-hours: Apr 1, 2025, 5:13 PM EDT

Atea Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-168.39-135.96-115.91121.19-10.95
Upgrade
Depreciation & Amortization
0.420.420.260.030.02
Upgrade
Loss (Gain) From Sale of Investments
-11.82-15.45-5.47--
Upgrade
Stock-Based Compensation
51.7749.4346.7239.627.46
Upgrade
Change in Accounts Receivable
-----5.82
Upgrade
Change in Accounts Payable
0.211.7-1.9810.29-0.49
Upgrade
Change in Unearned Revenue
----301.37301.37
Upgrade
Change in Other Net Operating Assets
-7.6814.46-44.643.235.14
Upgrade
Operating Cash Flow
-135.5-85.4-120.98-87.01296.73
Upgrade
Capital Expenditures
---1.94-0-0.03
Upgrade
Investment in Securities
56.1140.3-453.47--
Upgrade
Investing Cash Flow
56.1140.3-455.41-0-0.03
Upgrade
Issuance of Common Stock
0.270.260.371.47317.63
Upgrade
Other Financing Activities
-----0.02
Upgrade
Financing Cash Flow
0.270.260.371.47531.75
Upgrade
Net Cash Flow
-79.13-44.84-576.02-85.54828.46
Upgrade
Free Cash Flow
-135.5-85.4-122.93-87.01296.71
Upgrade
Free Cash Flow Margin
----24.76%610.10%
Upgrade
Free Cash Flow Per Share
-1.61-1.02-1.48-0.9913.74
Upgrade
Levered Free Cash Flow
-39.55-9.76-69.52-127.65300.81
Upgrade
Unlevered Free Cash Flow
-39.55-9.76-69.52-127.65300.81
Upgrade
Change in Net Working Capital
9.1-15.7245.11253.78-300.25
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q